|
Nov 8
|
Health Care Roundup: Market Talk
|
|
Nov 8
|
Bayer's (BAYRY) Q3 Earnings and Revenues Miss Estimates
|
|
Nov 8
|
Bayer’s CEO Weighs Breakup in U-Turn for German Conglomerate
|
|
Nov 8
|
Bayer’s new CEO signals business shake-up, plans to slash management
|
|
Nov 8
|
Bayer Weighs Structural Changes But Rules Out Three-Way Split
|
|
Nov 8
|
Bayer chief blasts conglomerate’s performance as ‘unacceptable’
|
|
Nov 8
|
Bayer CEO Serious About Structural Overhaul
|
|
Nov 8
|
UPDATE 4-Bayer weighs break-up options as management job cuts loom
|
|
Nov 8
|
Bayer weighs break-up options as management job cuts loom
|
|
Nov 7
|
UPDATE 2-Appeals court blocks California warning labels for glyphosate weedkillers
|
|
Nov 7
|
Appeals court blocks California warning requirement for glyphosate
|
|
Nov 3
|
California jury awards $332 million to man who blamed his cancer on use of Monsanto weedkiller
|
|
Nov 2
|
Regeneron (REGN) Q3 Earnings & Sales Top, Eylea Sales Decline
|
|
Nov 1
|
UPDATE 1-Bayer investor urges rethink after latest glyphosate defeat
|
|
Nov 1
|
Bayer investor urges rethink after latest glyphosate defeat
|
|
Oct 31
|
UPDATE 2-Bayer ordered to pay $332 mln in Roundup cancer trial
|
|
Oct 31
|
Bayer ordered to pay $332 million in Roundup cancer trial
|
|
Oct 31
|
Bayer ordered to pay $332 mln in Roundup cancer trial -Law.com
|
|
Oct 27
|
UPDATE 1-Bayer ordered to pay $175 mln in latest Roundup cancer trial
|
|
Oct 25
|
Bayer Aktiengesellschaft (ETR:BAYN) Delivered A Weaker ROE Than Its Industry
|